Latest Commercial Modelling News

Peppermint Innovation has secured major partnerships with ECPay and BTI Payments, vastly expanding its physical cash-in and bill payment network across the Philippines and enhancing accessibility for millions of cooperative members.

Dreadnought Resources announces a significant 36% increase in the high-grade Measured and Indicated gold resource at its Star of Mangaroon project, underpinning an updated open pit study and advancing commercial discussions.

Janus Electric has launched a strategic pilot project in Southern California, delivering battery-swapping Class 8 trucks and solar-powered infrastructure to revolutionize zero-emission freight at major U.S. ports.

Synertec Corporation has secured another order from Santos Limited for its Powerhouse renewable microgrid system at a remote Queensland gas site, reinforcing its role in decarbonising industrial energy supply.

Tetratherix Limited advances its Tetramatrix biomaterial platform with a robust IP portfolio, scalable manufacturing, and strategic partnerships aimed at commercialising across multiple clinical franchises.

WiseTech Global posted robust FY25 results with 14% revenue growth and a 53% EBITDA margin excluding acquisition costs, while finalising the strategic e2open acquisition to broaden its global logistics software footprint.

WiseTech Global reported robust FY25 results with a 14% revenue increase and a 53% EBITDA margin, boosted by strong CargoWise growth and the strategic acquisition of e2open. The company is poised to accelerate growth through AI innovations and a new commercial model.

Tabcorp Holdings Limited reported a robust FY25 with revenue climbing 11.8% and EBIT nearly doubling, driven by Victorian wagering licence reforms and disciplined cost management. The company’s strategic evolution and operational execution set the stage for modest growth in FY26.

Tabcorp Holdings Limited has reported a significant financial turnaround for FY25, driven by the new Victorian Wagering and Betting Licence and strategic operational improvements. The company posted $2.6 billion in revenue and a net profit after tax of $36.6 million, reversing last year's substantial loss.

Emyria has begun treating the first Medibank-funded PTSD patients at its Perth clinic, marking a pioneering step in private insurance coverage for psychedelic-assisted therapy in Australia. This milestone fuels rapid clinic expansion and supports the company’s national rollout strategy.

CSL Limited reported solid FY25 financials with 5% revenue growth and announced a strategic transformation including a $500 million annual cost saving target and plans to spin off its vaccine business, CSL Seqirus, as a separate ASX-listed entity.

Vitrafy Life Sciences reported a $32.7 million loss for FY25, driven by investments in its next-generation cryopreservation platform following a $35 million IPO and a $4.8 million government grant. The company is progressing commercialization efforts with key partnerships in human and animal health.